From Scotia: DRI Healthcare Trust DHT.U-T: US$10.24 Target: US$24.00 Old: US$22.00 Rating: Sector Outperform Out-year Revenue Runway Enhanced; Lifting Target to $24 OUR TAKE: Positive. Lifting the cap and expanding royalty interest in sales of pipeline drug, Omidria, is very favorable to our model and significantly mitigates royalty growth concerns beyond 2026 that the trust had
...more